Towards optimal patient selection for bronchial thermoplasty treatment in severe asthma: results from the TASMA randomized trial
A. Goorsenberg (Amsterdam, Netherlands), J. D'Hooghe (Amsterdam, Netherlands), N. Ten Hacken (Groningen, Netherlands), E. Weersink (Amsterdam, Netherlands), E. Bel (Amsterdam, Netherlands), P. Shah (London, United Kingdom), J. Annema (Amsterdam, Netherlands), P. Bonta (Amsterdam, Netherlands)
Source: International Congress 2019 – Clinical studies of asthma treatments
Session: Clinical studies of asthma treatments
Session type: Thematic Poster
Number: 2537
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Goorsenberg (Amsterdam, Netherlands), J. D'Hooghe (Amsterdam, Netherlands), N. Ten Hacken (Groningen, Netherlands), E. Weersink (Amsterdam, Netherlands), E. Bel (Amsterdam, Netherlands), P. Shah (London, United Kingdom), J. Annema (Amsterdam, Netherlands), P. Bonta (Amsterdam, Netherlands). Towards optimal patient selection for bronchial thermoplasty treatment in severe asthma: results from the TASMA randomized trial. 2537
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Efficacy of bronchial thermoplasty (BT) in patients with severe asthma: the AIR2 trial Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009 Year: 2009
A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma Source: Eur Respir J, 51 (1) 1701126; 10.1183/13993003.01126-2017 Year: 2018
The effect of salt room treatment on bronchial hyperresponsiveness in asthmatics: a randomised controlled trial Source: Eur Respir J 2005; 26: Suppl. 49, 505s Year: 2005
Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial Source: Eur Respir J 2007; 30: 457-466 Year: 2007
Long-term efficacy of a home-based airway clearance programme to improve cough severity in patients with bronchiectasis:a randomised controlled trial> Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections Year: 2019
Airway hyperresponsiveness to mannitol as a predictor of treatment response to ciclesonide in patients with suspected asthma: A double-blind, randomised, placebo-controlled trial Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease Year: 2012
A proof-of-concept randomized-controlled trial of omalizumab in patients with severe difficult to control nonatopic asthma Source: Annual Congress 2012 - Clinical diagnosis and treatment of adult asthma Year: 2012
Impact of bronchial thermoplasty on asthma status: interim results from the AIR trial Source: Eur Respir J 2006; 28: Suppl. 50, 114s Year: 2006
Can we predict response of refractory asthmatic cough to tiotropium? :a prospective study Source: Virtual Congress 2020 – Chronic cough: only symptom or disease? Year: 2020
Bronchial thermoplasty: a new therapeutic option for the treatment of severe, uncontrolled asthma in adults Source: Eur Respir Rev 2014; 23: 510-518 Year: 2014
Inhaled corticosteroids in patients with mild to moderate COPD with and without airway hyperresponsiveness to mannitol: A randomized placebo controlled trial Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011
A randomized controlled study of omalizumab in children with moderate-to-severe persistent allergic asthma Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma Year: 2008
A randomised controlled trial to investigate the optimal dose and effect of salbutamol for the treatment of acute exacerbations of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 244s Year: 2002
A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations Source: ERJ Open Res, 5 (4) 00136-2019; 10.1183/23120541.00136-2019 Year: 2019
ß-blockers in exacerbations of COPD: feasibility of a randomised controlled trial Source: ERJ Open Res, 3 (1) 00090-2016; 10.1183/23120541.00090-2016 Year: 2017
STEP-UP randomized controlled trial of vapor ablation in patients with severe emphysema: 12 month results Source: International Congress 2016 – Endoscopic lung volume reduction I Year: 2016
A feasibility, randomised controlled trial of a complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF): study protocol Source: ERJ Open Res, 5 (4) 00186-2019; 10.1183/23120541.00186-2019 Year: 2019
Self-titration of inhaled corticosteroid and ß2 -agonist in response to symptoms in mild asthma: a pre-specified analysis from the PRACTICAL randomised controlled trial Source: Eur Respir J, 56 (4) 2000170; 10.1183/13993003.00170-2020 Year: 2020
Effects of aerobic exercise on asthma control in eosinophilic asthma patients: a randomized controlled trial Source: International Congress 2018 – Clinical determinants of asthma and biomarkers Year: 2018
Real-life effectiveness of omalizumab in patients with severe persistent allergic asthma: the PERSIST study Source: Annual Congress 2009 - Towards improving asthma control Year: 2009